A discussion on how the economic burden of management differs for patients with HFpEF and HFrEF. Jaime Murillo, MD: What is the difference in economic burden between preserved and reduced ejection ...

Automatic positive airway pressure was found to significantly improve peak oxygen uptake, left ventricular function, and quality of life in patients with comorbid obstructive sleep apnea and heart ...

When added to standard therapies, omecamtiv mecarbil—a novel cardiac myosin activator, or myotrope—significantly reduces the combined risk of first heart failure events or CV death in patients with ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michelle M.

prescription medicine Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients. Heart failure affects ...

For patients who have heart failure with reduced ejection fraction (HFrEF) and coronary artery disease, improvements in LV function after revascularization are linked to better long-term outcomes, an ...

Please provide your email address to receive an email when new articles are posted on . PARIS — In patients with HF, with and without diabetes, treatment with the SGLT2 inhibitor dapagliflozin reduced ...

Please provide your email address to receive an email when new articles are posted on . Eplerenone was beneficial to patients regardless of how long they have had heart failure with reduced ejection ...

Start most patients newly diagnosed with heart failure with reduced ejection fraction on the disorder's four foundational drug regimens all at once, all on the day the diagnosis is made, Gregg C.

BOSTON, March 11, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a ...

Heart failure is a pathophysiological state in which an abnormality in cardiac function results in the failure of the heart to pump blood under normal cardiac pressures at a rate that meets the ...